Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 7


Results: 11
    1
    2
    3

    First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.

    Published in:
    HIV Medicine, 2018, v. 19, n. 7, p. 475, doi. 10.1111/hiv.12628
    By:
    • Taramasso, L.;
    • Di Biagio, A.;
    • Maggiolo, F.;
    • Tavelli, A.;
    • Lo Caputo, S.;
    • Bonora, S.;
    • Zaccarelli, M.;
    • Caramello, P.;
    • Costantini, A.;
    • Viscoli, C.;
    • d'Arminio Monforte, A.;
    • Cozzi‐Lepri, A.;
    • the Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Issue Information.

    Published in:
    HIV Medicine, 2018, v. 19, n. 7, p. 1, doi. 10.1111/hiv.12553
    Publication type:
    Article